Search for News

 

   

FDA Cautions Against Using Unapproved IUDs By Padman R	Sexually transmitted disease rates soar By Bloodindex News Bureau
Federal health officials are warning medical practitioners around the country not to use unapproved intrauterine devices (IUDs). In a July 22 letter, the Food and Drug Administration (FDA) reminds hea...read more	syphilis rates rose for a seventh year in 2007, driven by gay and bisexual men, while chlamydia reached record numbers and gonorrhea remained at alarming levels Blacks make up 12 percent of the U.S. population, but account for about 70 ...read more

Federal Agencies Issue Draft Guidance for Industry Good Importer Practices By Bloodindex News Bureau	FDA Launches Pilot Program To Improve the Safety of Drugs and Active Drug Ingredients Produced Outside the United States By Bloodindex News Bureau
The guidance is designed to provide guidance to importers on steps they can take to help ensure imported products are in compliance with applicable U.S. statutes and regulations. This draft guidance provides importers with recommendations to assist them ...read more	The U.S. Food and Drug Administration today announced the launch of a voluntary pilot program that would help promote the safety of drugs and active drug ingredients produced outside the United States. The FDA plans to select 100 applicants to participate in the Secure Supply ...read more

FDA Approves First Nucleic Acid Test to Screen for Additional Types of HIV in Donated Blood and Tissue By Bloodindex News Bureau	FDA Approves Drug for Patients with Advanced Prostate Cancer By Bloodindex News Bureau
The U.S. Food and Drug Administration today approved the cobas TaqScreen MPX Test, the first nucleic acid test that screens for the presence of two divergent types of HIV in donated blood plasma and tissue. “With the MPX test, blood donor testing laboratories will be able to use nu...read more	The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients with advanced prostate cancer. It b...read more

New insight into Alzheimer’s disease By Bloodindex News Bureau	Safe new therapy for genetic heart disease By Bloodindex News Bureau
A new molecule important in a part of the memory that allows recognition of people has been identified by researchers This type of memory is impaired at an early stage during Alzheimer’s diseas...read more	A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease. Hypertrophic cardiomyopathy, or HCM, is a genetic heart disease where the h...read more